1. Indole Antitumor Agents in Nanotechnology Formulations: An Overview
   Eleonora Russo et al, 2023, Pharmaceutics CrossRef
2. Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib
   Nana Huang et al, 2024, Frontiers in Oncology CrossRef